MDS Podcast What you missed: 2026 MDS Congress, Day 4
Dr. Genko Oyama gives us an inside look at the most exciting moments from the last full day of the MDS Congress — including 2 exciting Clinical Breakthrough announcements...
Stay up to date on novel, clinically-relevant research findings in Parkinson’s disease and other movement disorders.
All Episodes
MDS Podcast What you missed: 2026 MDS Congress, Day 3
Dr. Andrew Siderowf shares what you missed from #mdscongress day three, which included a deep dive into the evolving AI landscape and insightful live patient rounds.
MDS Podcast What you missed: 2026 MDS Congress, Day 1
Dr. Thomas Kimber breaks down the eventful and science-packed first day of the #MDSCongress.
MDS Podcast What you missed: 2026 MDS Congress, Day 2
Highlights from day 2: Dr. Sanjay Pandey recaps the key takeaways, including from the aging & comorbidities and renown awardee lecture sessions.
MDS Podcast Presidential Lecture Awardee: David Marsden Lecture Award | Congress 2026
Prof. Tiago Outeiro speaks with 2026 MDS Congress C. David Marsden Presidential Lecture Award winner Prof. Vincenzo Bonifati about his landmark genetic discoveries and the future of movement disorders...
MDS Podcast Junior Awardee: Prevalence of Parkinson’s in Kenya | Congress 2026
Sara Schaefer speaks with the MDS Congress 2026 Junior Award Winner Dr. Richard Morton about his prevalence study on Parkinson’s disease in Kalifi County, Kenya, a substudy of the...
MDS Podcast Junior Awardee: Can cortical signals tell us what is happening in the deep brain? | Congress 2026
In this episode, we speak with Zixiao Yin, recipient of a Junior Award at the MDS Congress, about his work on reconstructing deep brain activity from cortical signals. Using...
MDS Podcast Presidential Lecture Awardee: Stanley Fahn Award Lecture | Congress 2026
Dr. Sara Schaefer speaks with 2026 MDS Congress Stanley Fahn Award Lecture winner Dr. Beomseok Jeon about his career and the inspiration he drew from his time as a...
MDS Podcast Setting the TEMPO: What have we learned about D1/D5 dopamine stimulation in Parkinson’s disease?
Dr. Divyani Garg speaks with Dr. Hubert H. Fernandez about tavapadon, a once-daily selective dopamine D1/D5 receptor agonist, and what the TEMPO clinical development program tells us about its...